References
- VosTFlaxmanADNaghaviMYears lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet20123802163219623245607
- WilliamsHCDellavalleRPGarnerSAcne vulgarisLancet201137936137221880356
- StraussJSKrowchukDPLeydenJJAmerican Academy of Dermatology/American Academy of Dermatology AssociationGuidelines of care for acne vulgaris managementJ Am Acad Dermatol20075665166317276540
- NaglerARMilamECOrlowSJThe use of oral antibiotics before isotretinoin therapy in patients with acneJ Am Acad Dermatol Epub20151030
- LeydenJJMcGinleyKJCavalieriSWebsterGFMillsOHKligmanAMPropionibacterium acnes resistance to antibiotics in acne patientsJ Am Acad Dermatol1983841456219134
- IsclaIWrayRBlountPA new antibiotic with potent activity targets MscLJ Antibiot20156845346225649856
- JamesEViolaHHoolLEggersPKRastonCLBoulosRAA novel antimicrobial agent reduces oxidative stress in cellsRSC Adv2013372777281
- LengkeekNABoulosRAMcKinleyAJRileyTVMartinacBStewartSGThe synthesis of fluorescent DNA intercalator precursors through efficient multiple heck reactionsAust J Chem201164316323
- BoulosRAManNYLengkeekNAInspiration from old dyes: tris(stilbene) compounds as potent gram-positive antibacterial agentsChemistry201319179801798824248959
- RaoSPrestidgeCAMieselLSweeneyDShinabargerDLBoulosRAPreclinical development of Ramizol®, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitisJ Antibiot In press2016